FDA Seeks Feedback on Potential Regulation of GenAI Medical Devices

The FDA has issued a discussion paper seeking feedback on regulating generative AI-enabled medical devices, highlighting unique risks and challenges these devices pose compared to traditional medical software. The agency is considering a risk-based regulatory approach and new premarket and postmarket evaluation methodologies to ensure safety and effectiveness.

This Wire brief sits within Fusion42's coverage of Medtech, and 18 sources have reported it between 18 Aug 2026 and 11 Sep 2026.